FDA Drug Recalls

5,405 recalls, newest first

Jan 15, 2020 Class II · Moderate risk

Dexpanthenol Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0214-3 D-0952-2020

Jan 15, 2020 Class II · Moderate risk

Dexamethasone

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0630-1 D-0951-2020

Jan 15, 2020 Class II · Moderate risk

Deoxycholic Acid Sodium Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0462-3 D-0950-2020

Jan 15, 2020 Class II · Moderate risk

Cyanocobalamin/Folinic Acid Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0333-3 D-0949-2020

Jan 15, 2020 Class II · Moderate risk

Cyanocobalamin Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0330-3 D-0948-2020

Jan 15, 2020 Class II · Moderate risk

Coenzyme Q10 Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0411-1 D-0947-2020

Jan 15, 2020 Class II · Moderate risk

Calcium Chloride Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0225-3 D-0946-2020

Jan 15, 2020 Class II · Moderate risk

Biotin (Vitamin H)

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0220-3 D-0945-2020

Jan 15, 2020 Class II · Moderate risk

Betamethasone Acetate/Betamethasone

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0621-5 D-0944-2020

Jan 15, 2020 Class II · Moderate risk

Betamethasone Acetate/Betamethasone

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0621-1 D-0943-2020

Jan 15, 2020 Class II · Moderate risk

Betamethasone Acetate/Betamethasone

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0620-2 D-0942-2020

Jan 15, 2020 Class II · Moderate risk

B-Complex 110 Injectable

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0212-3 D-0941-2020

Jan 15, 2020 Class II · Moderate risk

AscorbiX (Buffered C)

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0226-5 D-0940-2020

Jan 15, 2020 Class II · Moderate risk

AscorbiX (Buffered C)

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0226-3 D-0939-2020

Jan 15, 2020 Class II · Moderate risk

Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate…

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0546-2 D-0938-2020

Jan 15, 2020 Class II · Moderate risk

Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate…

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0545-2 D-0937-2020

Jan 15, 2020 Class II · Moderate risk

Alprostadil

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0543-2 D-0936-2020

Jan 15, 2020 Class II · Moderate risk

Alprostadil

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0538-2 D-0935-2020

Jan 15, 2020 Class II · Moderate risk

Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0550-2 D-0934-2020

Jan 15, 2020 Class II · Moderate risk

Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0549-2 D-0933-2020

Jan 15, 2020 Class II · Moderate risk

Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0547-2 D-0932-2020

Dec 20, 2019 Class II · Moderate risk

Trimix Super

Lack of sterility assurance.

Terminated Sterility / contamination Assurance Infusion D-0779-2020

Dec 20, 2019 Class II · Moderate risk

TRIMIX FORTE PLUS 30MG/4MG/40MCG/ML INJ in 1 mL vial Assurance Infusion

Lack of sterility assurance.

Terminated Sterility / contamination Assurance Infusion D-0778-2020

Dec 20, 2019 Class II · Moderate risk

Trimix Forte 4

Lack of sterility assurance.

Terminated Sterility / contamination Assurance Infusion D-0777-2020

Dec 20, 2019 Class II · Moderate risk

TRIMIX FORTE 30MG/2MG/20MCG/ML INJ in 1 mL vial Assurance Infusion

Lack of sterility assurance.

Terminated Sterility / contamination Assurance Infusion D-0776-2020

Recalls by year

2026563
2025778
2024557
20231,122
20221,390
20211,152
2020930
20191,788
20181,681
20171,141
20161,199
20151,733
20141,309
20132,085
2012534
201134
20104
20072
20061